tiprankstipranks
Trending News
More News >

Neuronetics price target raised to $8 from $5 at Canaccord

Canaccord raised the firm’s price target on Neuronetics (STIM) to $8 from $5 and keeps a Buy rating on the shares. The firm said they reported Q4 revenue which was slightly ahead of guidance and management reiterated guidance which was issued in January.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue